Yves Petit

At Yields.io, we embed trust in an algorithm-driven world. The growing dependency of organizations on models, the introduction of advanced analytic techniques - such as Machine Learning - and the increasingly stringent regulatory guidelines have resulted in new challenges to manage model risk. Our clients leverage an award-winning data science platform, Chiron, to streamline their model lifecycle and turn model risk management into a value driver. For additional information, please visit our website: www.yields.io

FibriCheck is an innovative digital health company dedicated to transforming the way cardiac care is delivered. We do so by providing a medically certified, software-only and device-agnostic solution that redefines the way cardiac arrhythmias are detected and managed. We empower people to take control of their heart health by offering them our PPG-technology in a user-friendly setting. Users can measure their heart rhythm in 60 seconds, using the camera of their smartphone without any additional hardware. These measurements provide valuable insights into the heart rhythm which help people attain peace of mind and help to improve the outcomes of cardiac arrhythmias by speeding up the process of getting the right diagnosis and treatment. FibriCheck can be used throughout the entire patient lifecycle, from early detection and secondary prevention to the management of cardiac arrhythmias, such as atrial fibrillation (AF). On top of that, our software can also be used for symptom management such as palpitations, as symptoms can be logged with each measurement. These symptoms are combined with the results of the measurements in reports, which can easily be shared with physicians for further follow-up. Accuracy and safety are of the highest importance to us, which is why we make continuous efforts towards regulatory compliance and clinical validation. We are a CE class IIa medical device with regulatory approvals of the MHRA, FDA and TGA. FibriCheck is currently implemented by over 2000 clinical practices, and is the trusted partner in heart health for over 1 million users in 43 countries. Various integration possibilities are available. 📚 Want to learn about PPG-technology from our experts? bit.ly/3XmqU7r 🧑‍🏫 Curious about our clinical studies? bit.ly/3XkghCj 🤝 Interested in collaborating with FibriCheck? bit.ly/43h0UwQ 💡 Want to receive the latest news and product updates? bit.ly/3MF0ybM 🫶 Were always looking for ambitious people: bit.ly/30cT6gw

Meet 'Roger': the all-in-one platform for internal communication that helps you inform, connect and engage every single employee. Roger unifies all internal communication channels, allowing companies to manage their entire employee communication via one centralized dashboard. Sending the right message to the right employee at the right time, that's what we enable: creating, targeting, scheduling and analyzing internal messages was never this easy. Find out how it works via www.meetroger.io!

FibriCheck is an innovative digital health company dedicated to transforming the way cardiac care is delivered. We do so by providing a medically certified, software-only and device-agnostic solution that redefines the way cardiac arrhythmias are detected and managed. We empower people to take control of their heart health by offering them our PPG-technology in a user-friendly setting. Users can measure their heart rhythm in 60 seconds, using the camera of their smartphone without any additional hardware. These measurements provide valuable insights into the heart rhythm which help people attain peace of mind and help to improve the outcomes of cardiac arrhythmias by speeding up the process of getting the right diagnosis and treatment. FibriCheck can be used throughout the entire patient lifecycle, from early detection and secondary prevention to the management of cardiac arrhythmias, such as atrial fibrillation (AF). On top of that, our software can also be used for symptom management such as palpitations, as symptoms can be logged with each measurement. These symptoms are combined with the results of the measurements in reports, which can easily be shared with physicians for further follow-up. Accuracy and safety are of the highest importance to us, which is why we make continuous efforts towards regulatory compliance and clinical validation. We are a CE class IIa medical device with regulatory approvals of the MHRA, FDA and TGA. FibriCheck is currently implemented by over 2000 clinical practices, and is the trusted partner in heart health for over 1 million users in 43 countries. Various integration possibilities are available. 📚 Want to learn about PPG-technology from our experts? bit.ly/3XmqU7r 🧑‍🏫 Curious about our clinical studies? bit.ly/3XkghCj 🤝 Interested in collaborating with FibriCheck? bit.ly/43h0UwQ 💡 Want to receive the latest news and product updates? bit.ly/3MF0ybM 🫶 Were always looking for ambitious people: bit.ly/30cT6gw

At Yields.io, we embed trust in an algorithm-driven world. The growing dependency of organizations on models, the introduction of advanced analytic techniques - such as Machine Learning - and the increasingly stringent regulatory guidelines have resulted in new challenges to manage model risk. Our clients leverage an award-winning data science platform, Chiron, to streamline their model lifecycle and turn model risk management into a value driver. For additional information, please visit our website: www.yields.io

FibriCheck is an innovative digital health company dedicated to transforming the way cardiac care is delivered. We do so by providing a medically certified, software-only and device-agnostic solution that redefines the way cardiac arrhythmias are detected and managed. We empower people to take control of their heart health by offering them our PPG-technology in a user-friendly setting. Users can measure their heart rhythm in 60 seconds, using the camera of their smartphone without any additional hardware. These measurements provide valuable insights into the heart rhythm which help people attain peace of mind and help to improve the outcomes of cardiac arrhythmias by speeding up the process of getting the right diagnosis and treatment. FibriCheck can be used throughout the entire patient lifecycle, from early detection and secondary prevention to the management of cardiac arrhythmias, such as atrial fibrillation (AF). On top of that, our software can also be used for symptom management such as palpitations, as symptoms can be logged with each measurement. These symptoms are combined with the results of the measurements in reports, which can easily be shared with physicians for further follow-up. Accuracy and safety are of the highest importance to us, which is why we make continuous efforts towards regulatory compliance and clinical validation. We are a CE class IIa medical device with regulatory approvals of the MHRA, FDA and TGA. FibriCheck is currently implemented by over 2000 clinical practices, and is the trusted partner in heart health for over 1 million users in 43 countries. Various integration possibilities are available. 📚 Want to learn about PPG-technology from our experts? bit.ly/3XmqU7r 🧑‍🏫 Curious about our clinical studies? bit.ly/3XkghCj 🤝 Interested in collaborating with FibriCheck? bit.ly/43h0UwQ 💡 Want to receive the latest news and product updates? bit.ly/3MF0ybM 🫶 Were always looking for ambitious people: bit.ly/30cT6gw

Volta Ventures provides seed & early stage venture capital for internet & software companies in the Benelux region. The fund’s team, with active support from its network, expects to make a substantial impact by working with the founders and management to identify new markets and customers, hire senior talent, provide ongoing guidance, arrange further financing rounds and secure an exit.